Evidence map›Paper›PMID 29897625›Full record

ArticleEpilepsia2018

Effects of carbamazepine and lamotrigine on functional magnetic resonance imaging cognitive networks.

Fenglai Xiao, Lorenzo Caciagli, Britta Wandschneider, Josemir W Sander, Meneka Sidhu, Gavin Winston, Jane Burdett, Karin Trimmel, Andrea Hill, Christian Vollmar and 6 more

Open access · hybridAbstract readComparative StudyControlled Clinical Trial
In one paragraph

Article in Epilepsia, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Alterations in intra- and internetwork functional connectivity associated with levetiracetam treatment in temporal lobe epilepsy.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2020
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 4 countries.

Fenglai XiaoDepartment of Clinical and Experimental Epilepsy, University College London Institute of Neurology, London, UK.
Lorenzo CaciagliDepartment of Clinical and Experimental Epilepsy, University College London Institute of Neurology, London, UK.
Britta WandschneiderDepartment of Clinical and Experimental Epilepsy, University College London Institute of Neurology, London, UK.
Josemir W SanderDepartment of Clinical and Experimental Epilepsy, University College London Institute of Neurology, London, UK.ORCID 0000-0001-6041-9661
Meneka SidhuDepartment of Clinical and Experimental Epilepsy, University College London Institute of Neurology, London, UK.
Gavin WinstonDepartment of Clinical and Experimental Epilepsy, University College London Institute of Neurology, London, UK.ORCID 0000-0001-9395-1478
Jane BurdettMagnetic Resonance Imaging Unit, Epilepsy Society, Gerrards Cross, UK.
Karin TrimmelDepartment of Clinical and Experimental Epilepsy, University College London Institute of Neurology, London, UK.
Andrea HillMagnetic Resonance Imaging Unit, Epilepsy Society, Gerrards Cross, UK.
Christian VollmarDepartment of Neurology, Epilepsy Center, University of Munich, Munich, Germany.
Sjoerd B VosMagnetic Resonance Imaging Unit, Epilepsy Society, Gerrards Cross, UK.
Sebastien OurselinDepartment of Clinical and Experimental Epilepsy, University College London Institute of Neurology, London, UK.
Pamela J ThompsonDepartment of Clinical and Experimental Epilepsy, University College London Institute of Neurology, London, UK.
Dong ZhouDepartment of Neurology, West China Hospital of Sichuan University, Chengdu, Sichuan, China.ORCID 0000-0001-7101-4125
John S DuncanDepartment of Clinical and Experimental Epilepsy, University College London Institute of Neurology, London, UK.ORCID 0000-0002-1373-0681
Matthias J KoeppDepartment of Clinical and Experimental Epilepsy, University College London Institute of Neurology, London, UK.
University College London · GBEngineering and Physical Sciences Research Council · GBEpilepsy Society · GBSichuan University · CNLudwig-Maximilians-Universität München · DE

Funding

Wellcome Trust 203145Z/16/Z
6 · The paper itself

Abstract

objectiveTo investigate the effects of sodium channel-blocking antiepileptic drugs (AEDs) on functional magnetic resonance imaging (fMRI) language network activations in patients with focal epilepsy.

methodsIn a retrospective study, we identified patients who were treated at the time of language fMRI scanning with either carbamazepine (CBZ; n = 42) or lamotrigine (LTG; n = 42), but not another sodium channel-blocking AED. We propensity-matched 42 patients taking levetiracetam (LEV) as "patient-controls" and included further 42 age- and gender-matched healthy controls. After controlling for age, age at onset of epilepsy, gender, and antiepileptic comedications, we compared verbal fluency fMRI activations between groups and out-of-scanner psychometric measures of verbal fluency.

resultsPatients on CBZ performed less well on a verbal fluency tests than those taking LTG or LEV. Compared to either LEV-treated patients or controls, patients taking CBZ showed decreased activations in left inferior frontal gyrus and patients on LTG showed abnormal deactivations in frontal and parietal default mode areas. All patient groups showed fewer activations in the putamen bilaterally compared to controls. In a post hoc analysis, out-of-scanner fluency scores correlated positively with left putamen activation. SIGNIFICANCE: Our study provides evidence of AED effects on the functional neuroanatomy of language, which might explain subtle language deficits in patients taking otherwise well-tolerated sodium channel-blocking agents. Patients on CBZ showed dysfunctional frontal activation and more pronounced impairment of performance than patients taking LTG, which was associated only with failure to deactivate task-negative networks. As previously shown for working memory, LEV treatment did not affect functional language networks.

Indexed as

Magnetic Resonance ImagingAdolescentAdultAgedAnticonvulsantsBrainCarbamazepineCognitionDose-Response Relationship, DrugDrug Resistant EpilepsyEpilepsies, PartialFemaleHumansLamotrigineLevetiracetamMaleAnticonvulsantsCarbamazepineLamotrigineLevetiracetamantiepileptic drugscarbamazepinecognitionfunctional MRIlamotrigine

Identifiers

PMID29897625
PMCPMC6216427
OpenAlexW2807795330

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.